Thousand Oaks, California

TriasMD Acquires Thousand Oaks Surgery Center to Expand Model in Greater Los Angeles

Retrieved on: 
Thursday, March 21, 2024
Thousand Oaks, California, AAAHC, Partnership, Patient, DISC, Acquisition, Operating, ASC, Spine, Pain management, Elective surgery, Medicare, Podiatry, Physician, Otorhinolaryngology, Hospital

NEWPORT BEACH, Calif., March 21, 2024 /PRNewswire/ -- TriasMD, parent company of the DISC Surgery Centers, has announced its acquisition of Thousand Oaks Surgery Center (map it). This move continues the expansion of DISC's proven data/evidence-driven ambulatory surgery center (ASC) model throughout California and further increases accessibility for patients in Greater Los Angeles. Last year, TriasMD acquired Santa Clarita-based Gateway Surgery Center in February and Walnut Creek-based Pinnacle Surgery Center in October.

Key Points: 
  • NEWPORT BEACH, Calif., March 21, 2024 /PRNewswire/ -- TriasMD , parent company of the DISC Surgery Centers , has announced its acquisition of Thousand Oaks Surgery Center ( map it ).
  • This move continues the expansion of DISC's proven data/evidence-driven ambulatory surgery center (ASC) model throughout California and further increases accessibility for patients in Greater Los Angeles.
  • Last year, TriasMD acquired Santa Clarita-based Gateway Surgery Center in February and Walnut Creek-based Pinnacle Surgery Center in October.
  • Thousand Oaks Surgery Center – to be renamed DISC Surgery Center at Thousand Oaks – is an AAAHC-accredited, Medicare-certified facility featuring four spacious operating rooms, five private pre-op rooms, 11 recovery bays and two luxurious overnight suites for patients staying 23 hours or less.

Crumbl Cookies, the Nation’s Largest Cookie Company, Coming to Oaks Shopping Center

Retrieved on: 
Wednesday, June 22, 2022
Women, Restaurant, Bar, Men, Specialty, Family, Food, Beverage, Consumer, Retail, The Sundays, Thousand Oaks, California, Cookie, Flour, CEO, Egg, Family, Social media, COO, Egypt Road, Nova Scotia, Crumble, Multimedia, Friends, Furniture, Baking

Crumbl Cookies, the nation's largest cookie company, is set to serve cookie-crazed customers with its newest store in Oaks, Pennsylvania.

Key Points: 
  • Crumbl Cookies, the nation's largest cookie company, is set to serve cookie-crazed customers with its newest store in Oaks, Pennsylvania.
  • A grand opening is set for 8am on Thursday, June 30th in the Oaks Shopping Center at 1570 Egypt Road.
  • Having our customers see every cookie being made is one of the best experiences of our stores, said Sawyer Hemsley, Crumbl Co-founder & COO.
  • Crumbl is honored to be the largest cookie company in the nation and fastest growing restaurant franchise.

Dance Academy USA, the largest dance studio in California relocates their business during Covid

Retrieved on: 
Tuesday, January 4, 2022
San Jose State University, De Anza College, Come-Back!, Instability, Shane Company, Berkshire Hathaway, Silicon, Attitude, DAU, Oaks, Thousand Oaks, California, Student, Fitness, News, Warrior, Stevens Creek, Chin Na, Multimedia, Parent, Nightclub, COVID-19, Apple, Human Performance

Dance Academy USA is proud to note that it never stopped serving the community during the entire move, a move that happened in the middle of Covid.

Key Points: 
  • Dance Academy USA is proud to note that it never stopped serving the community during the entire move, a move that happened in the middle of Covid.
  • Co-owner Jane Carter said, "Our kids needed their dance friends and teachers more than ever during lockdown.
  • Dance Academy USA has a menu of class offerings that is one of the largest in California, and has been recognized by Dance Teacher Magazine as the #1 private dance studio in America.
  • "We literally did the impossible, and relocated a 31 year old business in the middle of Covid, that was admittedly damaged by Covid.

MannKind Corporation to Hold 2021 Second Quarter Financial Results Conference Call on August 11, 2021

Retrieved on: 
Wednesday, August 4, 2021
MannKind Corporation, Thousand Oaks, California, Nasdaq, Conference call, GlobeNewswire, Finance, Service industries, Companies

WESTLAKE VILLAGE, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2021 second quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, August 11, 2021.

Key Points: 
  • WESTLAKE VILLAGE, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2021 second quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, August 11, 2021.
  • Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven B. Binder.
  • Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at https://investors.mannkindcorp.com/events-and-presentations Events & Presentations.
  • MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases.

MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based On The Technosphere® Platform

Retrieved on: 
Wednesday, August 4, 2021
MannKind Corporation, Thousand Oaks, California, Inhalable insulin, Technosphere, Nrx, Medication, Health sciences, Medicine, Health care

"We are pleased to be working with MannKind to develop an inhaled form of ZYESAMI which may offer patients an easier and more therapeutic option."

Key Points: 
  • "We are pleased to be working with MannKind to develop an inhaled form of ZYESAMI which may offer patients an easier and more therapeutic option."
  • MannKind was established in 1991, and is headquartered in Westlake Village, Calif., with a manufacturing and R&D facility based in Danbury, Conn.
  • Forward-looking statements include statements regarding the potential to create a dry powder formulation of a new compound and to treat certain diseases.
  • ZYESAMI is a trademark of NRx Pharmaceuticals, Inc.
    AFREZZA and TECHNOSPHERE are registered trademarks of MannKind Corporation.

MannKind Corporation to Participate in the BTIG Virtual Biotechnology Conference 2021

Retrieved on: 
Tuesday, August 3, 2021
MannKind Corporation, Thousand Oaks, California

WESTLAKE VILLAGE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat in the BTIG Virtual Biotechnology Conference 2021 on Tuesday, August 10, 2021 at 12:30 PM (ET).

Key Points: 
  • WESTLAKE VILLAGE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat in the BTIG Virtual Biotechnology Conference 2021 on Tuesday, August 10, 2021 at 12:30 PM (ET).
  • BTIG hosted events are intended for prospective and existing BTIG clients only.
  • MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases.
  • MannKind was established in 1991, and is headquartered in Westlake Village, Calif., with a manufacturing and R&D facility in Danbury, Conn.

RabbleHealth Appoints Former Kaiser Permanente Executive Mitch Ross to Advisory Board

Retrieved on: 
Tuesday, August 3, 2021
States of the United States, California, Healthcare in the United States, Health insurance in the United States, Healthcare in California, Henry J. Kaiser, Kaiser Permanente, Non-profit organizations based in California, University of California, Los Angeles, Thousand Oaks, California, Mitch, Irvine, California

THOUSAND OAKS, Calif., Aug. 3, 2021 /PRNewswire/ -- RabbleHealth announced today that it has appointed Mitch Ross, former Vice President, Individual and Family Plans for Kaiser Permanente, to its Advisory Board.

Key Points: 
  • THOUSAND OAKS, Calif., Aug. 3, 2021 /PRNewswire/ -- RabbleHealth announced today that it has appointed Mitch Ross, former Vice President, Individual and Family Plans for Kaiser Permanente, to its Advisory Board.
  • Mitch is an experienced healthcare executive, consultant, and advisor.
  • Prior to that, Mitch held various executive and leadership roles at healthcare organizations including Blue Shield of California and CareAmerica Health Plans.
  • Mitch earned his MBA from the Anderson School of Management at UCLA and his Bachelor of Arts Degree in Economics from UC Irvine.

Amgen Appoints S. Omar Ishrak To Board Of Directors

Retrieved on: 
Friday, July 30, 2021
Industry economics), Companies, Articles, Omar Ishrak, Amgen, Robert A. Bradway, Intel, Conejo Valley, Thousand Oaks, California, Board of directors

THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of S. Omar Ishrak to its Board of Directors, effective immediately.

Key Points: 
  • THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of S. Omar Ishrak to its Board of Directors, effective immediately.
  • Following the appointment of Dr. Ishrak, the Board will be composed of 12 directors, 11 of whom are independent.
  • "Omar is an accomplished business leader with deep experience in a fast-paced, technology-driven sector of the healthcare industry," said Robert A. Bradway, chairman and chief executive officer of Amgen.
  • Dr. Ishrak has been a director of Intel Corporation since 2017 and was named chairman of the board in January 2020.

Amgen Announces Webcast Of 2021 Second Quarter Financial Results

Retrieved on: 
Thursday, July 29, 2021
Industry economics), Life sciences, Pharmaceutical industry, Amgen, Robert A. Bradway, NASDAQ, Thousand Oaks, California

THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, August 3, 2021, after the close of the U.S. financial markets.

Key Points: 
  • THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, August 3, 2021, after the close of the U.S. financial markets.
  • Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
  • Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.
  • The webcast will be archived and available for replay for at least 90 days after the event.

Dry Powder Inhaler Devices Pipeline Product Market Landscape Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 6, 2021
Medical devices, Health, MannKind Corporation, Thousand Oaks, California, Teva Pharmaceuticals, Nektar, Companies, Life sciences, Pharmaceutical companies

6.4 Apr 27, 2021: Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth.

Key Points: 
  • 6.4 Apr 27, 2021: Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth.
  • Group guidance for FY 2021 confirmed
    6.13 Mar 02, 2021: MannKind to Participate in H.C. Wainwright Global Life Sciences Conference
    6.14 Mar 01, 2021: Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference
    6.15 Feb 18, 2021: MannKind to Hold 2020 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2021
    6.17 Feb 18, 2021: Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021
    6.19 Feb 18, 2021: Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021, After Close of U.S.-Based Financial Markets
    6.25 Jan 06, 2021: Nektar Therapeutics' President and CEO, Howard Robin, to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference
    6.26 Jan 04, 2021: MannKind to Participate in H.C. Wainwright Bioconnect 2021 Conference
    6.31 Jul 09, 2020: Teva to Host Conference Call to Discuss Second Quarter 2020 Financial Results at 8 a.m.
  • ET on August 5, 2020
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210706005382/en/